Clarius Group LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $475K | Sell |
|
|||||
|
2025
Q2 | $572K | Sell |
|
|||||
|
2025
Q1 | $716K | Buy |
|
|||||
|
2024
Q4 | $442K | Sell |
|
|||||
|
2024
Q3 | $673K | Sell |
|
|||||
|
2024
Q2 | $691K | Sell |
|
|||||
|
2024
Q1 | $652K | Sell |
|
|||||
|
2023
Q4 | $687K | Sell |
|
|||||
|
2023
Q3 | $653K | Sell |
|
|||||
|
2023
Q2 | $720K | Buy |
|
|||||
|
2023
Q1 | $806K | Buy |
|
|||||
|
2022
Q4 | $685K | Buy |
|
|||||
|
2022
Q3 | $573K | Hold |
|
|||||
|
2022
Q2 | $492K | Buy |
|
|||||
|
2022
Q1 | $499K | Hold |
|
|||||
|
2021
Q4 | $499K | Buy |
|
|||||
|
2021
Q3 | $428K | Buy |
|
|||||
|
2021
Q2 | $370K | Sell |
|
|||||
|
2021
Q1 | $316K | Buy |
|
|||||
|
2020
Q4 | $297K | Buy |
|
|||||
|
2020
Q3 | $311K | Sell |
|
|||||
|
2020
Q2 | $410K | Buy |
|